1108-118 Comparative yield of clinical, laboratory, echocardiographic, and neurohormonal predictors of outcome in heart failure patients (Val-HeFT data)

Lidia Staszewsky; Maylene Wong; Simona Barlera; Elisa Carretta; Serge Masson; Roberto Latini; Aldo Maggioni; Jay N. Cohn; Gianni Tognoni

doi:10.1016/s0735-1097(04)90845-5

Back

Shared by

Aldo Maggioni

1108-118 Comparative yield of clinical, laboratory, echocardiographic, and neurohormonal predictors of outcome in heart failure patients (Val-HeFT data)

Article 2004 en

Authors

LS
Lidia Staszewsky
MW
Maylene Wong
SB
Simona Barlera

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2007

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

Lidia Staszewsky, Maylene Wong, Serge Masson, Simona Barlera, Elisa Carretta, Aldo Maggioni, Inder S. Anand, Jay N. Cohn, Gianni Tognoni, Roberto Latini

Article2010

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

Serge Masson, Scott D. Solomon, Laura Angelici, Roberto Latini, Inder S. Anand, Margaret F. Prescott, Aldo Maggioni, Gianni Tognoni, Jay N. Cohn

Article2003

Prognostic Value of Aldosterone in Heart Failure – Results from Val-HeFT

Inder S. Anand, Roberto Latini, Robert Glazer, Allen Hester, Serge Masson, Aldo Maggioni, Nora Aknay, Jay N. Cohn

Article2003

1928 The prognostic value of body mass index in patients with heart failure: data from the Val-HeFT trial

Aldo Maggioni

Article2005

Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results From the Valsartan Heart Failure Trial (Val-HeFT)

Aldo Maggioni, Roberto Latini, Peter E. Carson